Philip E. Castle
Impact in
- Epidemiology top 0.01%
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
- Microbiology top 0.05%
- Reproductive tract infections research
Papers in
- Epidemiology 313
- Cervical Cancer and HPV Research 310
- Hepatitis B Virus Studies 34
- Surgery 65
- Genital Health and Disease 59
- Co-authors
- Mark Schiffman (139 shared papers)Sholom Wacholder (31 shared papers)Ana Cecilia Rodríguez (21 shared papers)Diane Solomon (32 shared papers)José Jerónimo (23 shared papers)Nicolas Wentzensen (72 shared papers)Cosette M. Wheeler (47 shared papers)Walter Kinney (58 shared papers)
- Journals
- International Journal of Cancer (29 papers)Journal of Lower Genital Tract Disease (29 papers)Cancer Epidemiology Biomarkers & Prevention (26 papers)Journal of Clinical Microbiology (18 papers)JNCI Journal of the National Cancer Institute (18 papers)
- Partner nations
- United StatesCosta RicaUnited Kingdom
In The Last Decade
Philip E. Castle
343 papers receiving 25.3k citations
Philip E. Castle's Hit Papers
Peers
Comparison fields: 5 of 163
- Epidemiology 21.4k
- Microbiology 2.1k
- Obstetrics and Gynecology 1.8k
- Oncology 3.8k
- Surgery 5.0k
Countries citing papers authored by Philip E. Castle
This map shows the geographic impact of Philip E. Castle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip E. Castle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip E. Castle more than expected).
Fields of papers citing papers by Philip E. Castle
This network shows the impact of papers produced by Philip E. Castle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip E. Castle. The network helps show where Philip E. Castle may publish in the future.
Co-authors
The 25 scholars most cited alongside Philip E. Castle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 348 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Human papillomavirus and cervical cancer Hit paper breakdown → | 2007 | 2259 |
| 2 | American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer Hit paper breakdown → | 2012 | 1065 |
| 3 | The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice Hit paper breakdown → | 2005 | 854 |
| 4 | 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors Hit paper breakdown → | 2020 | 794 |
| 5 | American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer Hit paper breakdown → | 2012 | 768 |
| 6 | American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer Hit paper breakdown → | 2012 | 648 |
| 7 | Human Papillomavirus Testing in the Prevention of Cervical Cancer Hit paper breakdown → | 2011 | 582 |
| 8 | Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses Hit paper breakdown → | 2018 | 548 |
| 9 | Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older Hit paper breakdown → | 2008 | 544 |
| 10 | 2005 | 439 | |
| 11 | Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice Hit paper breakdown → | 2011 | 432 |
| 12 | 2008 | 421 | |
| 13 | Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study Hit paper breakdown → | 2011 | 416 |
| 14 | 2007 | 404 | |
| 15 | Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study Hit paper breakdown → | 2019 | 341 |
| 16 | 2007 | 324 | |
| 17 | 2005 | 316 | |
| 18 | 2005 | 311 | |
| 19 | 2004 | 311 | |
| 20 | 2009 | 309 |
About Philip E. Castle
Philip E. Castle is a scholar working on Epidemiology, Surgery, Oncology, Molecular Biology and Microbiology, having authored 348 papers that have together received 26.3k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (310 papers), Genital Health and Disease (59 papers), Global Cancer Incidence and Screening (48 papers), Hepatitis B Virus Studies (34 papers), Molecular Biology Techniques and Applications (24 papers), Reproductive tract infections research (23 papers), Endometrial and Cervical Cancer Treatments (20 papers) and Colorectal Cancer Screening and Detection (8 papers). The work is most often cited by research in Epidemiology (21.4k citations), Microbiology (2.1k citations), Obstetrics and Gynecology (1.8k citations), Oncology (3.8k citations) and Surgery (5.0k citations). Philip E. Castle has collaborated with scholars based in United States, Costa Rica and United Kingdom. Frequent co-authors include Mark Schiffman, Sholom Wacholder, Ana Cecilia Rodríguez, Diane Solomon, José Jerónimo, Nicolas Wentzensen, Cosette M. Wheeler, Walter Kinney, Mark H. Stoler and Julia C. Gage. Their work appears in journals such as International Journal of Cancer, Journal of Lower Genital Tract Disease, Cancer Epidemiology Biomarkers & Prevention, Journal of Clinical Microbiology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.